172 related articles for article (PubMed ID: 31418658)
21. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.
Cong WM; Bu H; Chen J; Dong H; Zhu YY; Feng LH; Chen J;
World J Gastroenterol; 2016 Nov; 22(42):9279-9287. PubMed ID: 27895416
[TBL] [Abstract][Full Text] [Related]
22. Rhabdomyosarcoma: review for the ophthalmologist.
Shields JA; Shields CL
Surv Ophthalmol; 2003; 48(1):39-57. PubMed ID: 12559326
[TBL] [Abstract][Full Text] [Related]
23. An update on ocular adnexal lymphoma.
Mulay K; Honavar SG
Semin Diagn Pathol; 2016 May; 33(3):164-72. PubMed ID: 26972223
[TBL] [Abstract][Full Text] [Related]
24. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
25. BRAF mutation testing in melanoma: results from a German observational multicenter study.
Hartmann A; Schirmacher P; Sterlacci W; Koch W; Liesenfeld DB; Schif B; Garbe C
Virchows Arch; 2019 Jan; 474(1):71-78. PubMed ID: 30406424
[TBL] [Abstract][Full Text] [Related]
26. Molecular predictive testing in precision oncology: The Italian experience.
Vigliar E; Iaccarino A; Sciortino M; De Luca C; Malapelle U; Bellevicine C; Troncone G
Cancer Cytopathol; 2020 Sep; 128(9):622-628. PubMed ID: 32885914
[TBL] [Abstract][Full Text] [Related]
27. Predictive pathology in routine diagnostics of solid tumors.
Lassmann S; Werner M
Histol Histopathol; 2012 Mar; 27(3):289-96. PubMed ID: 22237706
[TBL] [Abstract][Full Text] [Related]
28. Recent advancements in the management of retinoblastoma and uveal melanoma.
Schefler AC; Kim RS
F1000Res; 2018; 7():. PubMed ID: 29755733
[TBL] [Abstract][Full Text] [Related]
29. Malignant uveitis masquerade syndromes.
Kubicka-Trzaska A; Romanowska-Dixon B
Klin Oczna; 2008; 110(4-6):199-202. PubMed ID: 18655462
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic and immunotherapeutic targets in metastatic melanoma.
Melis C; Rogiers A; Bechter O; van den Oord JJ
Virchows Arch; 2017 Aug; 471(2):281-293. PubMed ID: 28357489
[TBL] [Abstract][Full Text] [Related]
31. [TNM classification of ophthalmic malignant tumors].
Kaneko A
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1231-40. PubMed ID: 9679589
[TBL] [Abstract][Full Text] [Related]
32. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
33. An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology.
Kalampokas E; Payne F; Nomikos A; Gurumurthy M
Gynecol Oncol; 2018 Aug; 150(2):378-386. PubMed ID: 29792263
[TBL] [Abstract][Full Text] [Related]
34. Molecular testing in malignant melanoma.
Grossmann AH; Grossmann KF; Wallander ML
Diagn Cytopathol; 2012 Jun; 40(6):503-10. PubMed ID: 22619125
[TBL] [Abstract][Full Text] [Related]
35. [Focus on application of pathological examination in treatment of ocular tumours].
Li YP
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):289-91. PubMed ID: 20654051
[TBL] [Abstract][Full Text] [Related]
36. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists.
Kakavand H; Wilmott JS; Long GV; Scolyer RA
Pathology; 2016 Feb; 48(2):194-202. PubMed ID: 27020392
[TBL] [Abstract][Full Text] [Related]
38. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
39. [Hopes and pitfalls of the molecular classification of breast cancer].
Ryška A; Hovorková E; Sobande F; Rozkoš T; Laco J; Hornychová H
Cesk Patol; 2015; 51(1):26-32. PubMed ID: 25671359
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
